PFKP and non-small cell lung carcinoma: To assess the role of PFKP in HBO therapy in vivo, we used a murine model of NSCLC to measure tumorigenesis in normoxic control or HBO-treated C57BL/6J mice tail-vein injected with control or Pfkp-overexpressing LLC cells (Figure 4A).